Healios K.K.
HLOSF
Price:
$3.4
Market Cap:
$43.03B
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company is also developing cellular and tissue-based products comprising HLCR011 and HLCR012 that are iPSC regenerative medicines for the treatment of age-related macular degeneration; HLCL041, an iPSC regenerative medicine for the treatment of metabolic liver disease; and HLCM051, a regenerative medicine for treatment of ischemic stroke and acute respiratory distress syndrome, as well as HLCN061 for treating solid tumors. Healios K.K. has a joint research agreement with the Hyogo Medical University on cancer immunotherapi...[Read more]
Industry
Biotechnology
IPO Date
2020-11-09
Stock Exchange
OTC
Ticker
HLOSF
PE Ratio
[-8.72]
ROE
[-342.79%]
Current Ratio
[1.06]
Dividend Yield
[0%]
Enterprise Value
[39.39B]
Dividend History
The ROE as of December 2025 (TTM) for Healios K.K. (HLOSF) is -342.79%
According to Healios K.K.’s latest financial reports and current stock price. The company's current ROE is -342.79%. This represents a change of 261.51% compared to the average of -94.82% of the last 4 quarters.
Healios K.K. (HLOSF) Historical ROE (quarterly & annually)
How has HLOSF ROE performed in the past?
The mean historical ROE of Healios K.K. over the last ten years is -72.44%. The current -342.79% ROE has changed 373.19% with respect to the historical average. Over the past ten years (40 quarters), HLOSF's ROE was at its highest in in the December 2024 quarter at 12.41%. The ROE was at its lowest in in the June 2025 quarter at -171.16%.
Average
-72.44%
Median
-57.07%
Minimum
-205.28%
Maximum
-10.22%
Healios K.K. (HLOSF) ROE by Quarter and Year
Discovering the peaks and valleys of Healios K.K. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 460.61%
Maximum Annual ROE = -10.22%
Minimum Annual Increase = -80.81%
Minimum Annual ROE = -205.28%
| Year | ROE | Change |
|---|---|---|
| 2024 | -205.28% | 107.06% |
| 2023 | -99.14% | -15.97% |
| 2022 | -117.98% | 107.50% |
| 2021 | -56.86% | -19.10% |
| 2020 | -70.28% | 43.12% |
| 2019 | -49.11% | 3.88% |
| 2018 | -47.27% | 330.08% |
| 2017 | -10.99% | -80.81% |
| 2016 | -57.28% | 460.61% |
| 2015 | -10.22% | -42.95% |
Healios K.K. (HLOSF) Average ROE
How has HLOSF ROE performed in the past?
The current ROE of Healios K.K. (HLOSF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-140.80%
5-year avg
-109.91%
10-year avg
-72.44%
Healios K.K. (HLOSF) ROE vs. Peers
How is HLOSF’s ROE compared to its peers?
Healios K.K.’s ROE is greater than Avacta Group Plc (-43.42%), greater than BioInvent International AB (publ) (-41.14%), less than Northwest Biotherapeutics, Inc. (92.80%), less than PureTech Health plc (12.82%), less than MedinCell S.A. (64.48%), less than CytoDyn Inc. (22.25%), greater than Immutep Limited (-38.87%), less than Clinuvel Pharmaceuticals Limited (15.79%), greater than Cresco Labs Inc. (-9.94%), greater than Cellectis S.A. (-49.81%),
| Company | ROE | Market cap |
|---|---|---|
| -43.42% | $481.37M | |
| -41.14% | $216.40M | |
| 92.80% | $357.44M | |
| 12.82% | $406.03M | |
| 64.48% | $230.71M | |
| 22.25% | $415.38M | |
| -38.87% | $264.95M | |
| 15.79% | $393.07M | |
| -9.94% | $300.34M | |
| -49.81% | $325.46M |
Build a custom stock screener for Healios K.K. (HLOSF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Healios K.K. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Healios K.K. (HLOSF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Healios K.K. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Healios K.K.'s ROE?
How is the ROE calculated for Healios K.K. (HLOSF)?
What is the highest ROE for Healios K.K. (HLOSF)?
What is the 3-year average ROE for Healios K.K. (HLOSF)?
What is the 5-year average ROE for Healios K.K. (HLOSF)?
How does the current ROE for Healios K.K. (HLOSF) compare to its historical average?